Aurora, Colorado 80045


Purpose:

Excess maternal weight, especially obesity, influences almost every aspect of fertility, from conception to problems during pregnancy. The investigators will use novel statistical methods to clarify the hormonal changes behind reproductive health conditions. A better understanding of reproductive hormonal changes in obese women may offer a way to identify new treatments.


Study summary:

Hypothesis. Insufficient FSH (Follicle-stimulating hormone) pulsatility, as seen in obesity, results in inadequate folliculogenesis and reduced ovarian steroid and protein production. AIM: To test the hypothesis that insufficient FSH pulsatility, as seen in obesity, results in inadequate folliculogenesis and reduced ovarian steroid and protein production. The investigators will determine if exogenous FSH administered in a pulsatile fashion results in a significant increase of ovarian hormones in obese women. Serial inhibin B and E2 levels will be measured in obese and normal weight women undergoing frequent blood sampling studies before and after GnRH (Gonadotropin-releasing hormone) antagonist blockade.


Criteria:

Inclusion Criteria: - Age between 21 to 39 years old with regular menstrual cycles every 25-40 days - Body mass of 18.5 kg/m2-24.9kg/m2 (normal weight controls) or greater than 30.0 kg/m2 (obese group) - Prolactin and thyroid-stimulating hormone (TSH) within normal laboratory ranges at screening - Baseline hemoglobin >11 gm/dl. Exclusion Criteria: - Diagnosis of polycystic ovary syndrome (PCOS), defined by the 2003 Rotterdam criteria as suggested by 2012 NIH Workshop - History of chronic disease affecting hormone production, metabolism or clearance or use of thiazolidinediones or metformin (known to interact with reproductive hormones) - Use of hormones affecting hypothalamic-pituitary-gonadal (HPO) axis (such as hormonal contraceptives) within 3 months of entry - Strenuous exercise (>4 hours of intense physical activity per week) - Pregnancy - Breast-feeding - Current attempts to conceive - Significant recent weight loss or gain


NCT ID:

NCT02478775


Primary Contact:

Principal Investigator
Alex Polotsky, MD
University of Colorado, Denver

Anahit Malkhasyan
Phone: 303-724-5276
Email: anahit.malkhasyan@ucdenver.edu


Backup Contact:

Email: chanel.mansfield@ucdenver.edu
Chanel Mansfield
Phone: 303-724-6501


Location Contact:

Aurora, Colorado 80045
United States

Chanel Mansfield, BBA
Phone: 303-724-6501
Email: chanel.mansfield@ucdenver.edu

Site Status: Recruiting


Data Source: ClinicalTrials.gov

Date Processed: November 18, 2017

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

If you would like to be contacted by the clinical trial representative please fill out the form below.